Cadence for Cancer

Jan 05, 2010 08:00 ET ImmuneRegen BioSciences® Reports Additional Positive Results From Study of Homspera® in Treating Highly Pathogenic Influenza New Data Reveal Homspera Reduced the Levels of Influenza Virus Particles in Infected Animals SCOTTSDALE, AZ--(Marketwire - January 5, 2010) - ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced additional positive ...

Thursday, December 24, 2009 ImmuneRegen BioSciences® Summarizes Previous 9 Months of Advances as Homspera® Development Continues SCOTTSDALE, AZ--(Marketwire - December 24, 2009) - ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), ends 2009 with a significantly deeper understanding of the mechanisms underlying the demonstrated immunostimulatory activity of its development candidate Homspera®, and ...

Big problem, cyclists jumping red lights in London. Not necessarily the "Lycra" brigade. Real people in proper clothes! Would I like to see just how bad it is? Yes. So this morning I joined a police operation to ‘nab red light jumping cyclists'.Location posh Belgravia, junction of Ebury And Eccleston Streets, SW1, near Victoria Coach Station ...

Make sure to check out this blog that I came across! www.bicyclecomicjokes.blogspot.com

I almost got hit 3 times the other evening! Twice in intersections where the drivers just don't look up and for a cyclist coming through. Also, I watch people driving IN the bike lane and often pull them over to tell them. I am obnoxious, but they NEED to know. They MUST know and it is my ...

"Increased levels of vitamin D and calcium may play a protective role in colorectal cancer (CRC) risk. It has been suggested that these effects may be mediated by genetic variants of the vitamin D receptor (VDR) and the calcium sensing receptor (CASR)," scientists in Lyon, France report. "However, current epidemiologic evidence from European populations for a ...

ROCHESTER, Minn. -- Doctors and their patients with a specific type of breast cancer called ductal carcinoma in situ (DCIS) are successfully employing treatments to beat the disease, with 10-year survival rates approaching nearly 100 percent. But questions remain on how aggressively to treat this cancer. The October issue of Mayo Clinic Women's HealthSource lays out ...

Recently implicated in some severe prostate cancer patients, the retrovirus XMRV has now been found in many with chronic fatigue--changing the landscape for diagnosis and possible treatment More so than many illnesses, chronic fatigue syndrome (CFS) frustrates those who suffer from it and those close to them, due to its nebulous assembly of symptoms, along with ...

Elizabeth Blackburn, Carol Greider and Jack Szostak are recognized for research into telomeres--a key chromosome component--and the related enzyme telomerase The 2009 Nobel Prize in Physiology or Medicine will go to three Americans who discovered telomeres, the genetic code that protects the ends of chromosomes, and telomerase, the enzyme that assists in this process, findings that are important ...

An unusual enzyme called telomerase acts on parts of chromosomes known as telomeres. The enzyme has recently been found in many human tumors and is being eyed as a new target for cancer therapy Editor's note: We are posting the main text of this article from the February 1996 issue of Scientific American for all our readers ...